Several inflammatory indicators have been shown to predict the prognosis of patients with glioma, including platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), and the albumin to globular albumin ratio (AGR) (4–6). The gene discussed is ALB; the disease is glioma.